MannKind Corporation (NASDAQ:MNKD) has been in free-fall mode lately. After shedding more than 7% last Friday on Food and Drug Administration (FDA) concerns, the pharmaceutical stock is down another 16% this afternoon at $4.07, thanks to a bearish brokerage note from Piper Jaffray earlier. MannKind Corporation (NASDAQ:MNKD) stock performance was -16.77% in last session and finished the day at $4.02. Traded volume was 30,207,668 million shares in the last session and the average volume of the stock remained 7.92 million shares. The beta of the stock remained 1.47. MannKind Corporation (NASDAQ:MNKD) insider ownership is 0.60%.
Shares of Prana Biotechnology (NASDAQ:PRAN) were the recipient of some unusual options trading activity on Monday. Stock traders purchased 7,567 put options on the company,StockRatingsNetwork.com reports. This represents an increase of 277% compared to the average daily volume of 2,007 put options. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) dropped -71.60 percent to $2.80 yesterday on volume of 23.73 million shares. The intra-day range of the stock was $2.78 to $3.24. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) has a market capitalization of $116.61 million.
Biofuel Energy (Nasdaq:BIOF) announced that it has received a preliminary non-binding proposal from Greenlight Capital, Inc., and James R. Brickman for a possible transaction pursuant to which one or more newly-formed, wholly owned subsidiaries of the Company would acquire all of the equity interests of JBGL Capital, LP and JBGL Builder Finance, LLC, and their direct and indirect subsidiaries. BioFuel Energy Corp. (NASDAQ:BIOF)’s stock on Mar 31, 2014 reported a increase of 132.48% to the closing price of $7.30. Its fifty two weeks range is $1.13 -$7.80. The total market capitalization recorded $45.84 million. The overall volume in the last trading session was 18,072,744 million shares. In its share capital, BioFuel Energy Corp. (NASDAQ:BIOF) has 5.45 million outstanding shares.
American Capital Ltd. (NASDAQ:ACAS) on Mar. 31 announced that in the first quarter of 2014, it made open market purchases of 8.9 million shares of American Capital common stock, or 3.3% of the Company’s outstanding shares as of December 31, 2013. On Monday, shares of American Capital Ltd. (NASDAQ:ACAS) advanced 11.15% to close the day at $15.80. Company return on investment (ROI) is 3.10% and its monthly performance is recorded as 1.51%. American Capital Ltd. (NASDAQ:ACAS) quarterly revenue growth is 2.10%.